definit
asthma
base
function
dispar
underli
inflamm
asthma
chronic
inflammatori
disord
airway
mani
cell
cellular
element
play
role
chronic
inflamm
associ
airway
hyperrespons
lead
recurr
episod
wheez
breathless
chest
tight
cough
particularli
night
earli
morn
episod
usual
associ
widespread
variabl
airflow
obstruct
lung
often
revers
either
spontan
treatment
asthma
nomenclatur
well
definit
diseas
sever
manag
goal
chang
substanti
recent
year
move
away
system
predominantli
base
lung
function
symptom
toward
one
base
therapeut
method
dose
requir
achiev
diseas
control
airway
inflamm
central
driver
chronic
intermitt
natur
asthma
symptom
eventu
end
sever
asthma
attack
inflamm
affect
airway
upper
respiratori
tract
small
airway
although
physiolog
effect
believ
pronounc
mediums
bronchi
prevent
therapeut
inhibit
inflammatori
process
may
lead
deterior
diseas
asthma
attack
potenti
life
threaten
acut
worsen
mani
ground
like
insuffici
treatment
exercis
allerg
trigger
cold
air
also
infecti
microorgan
review
provid
overview
research
publish
cellular
basi
diseas
assess
role
viru
bacteria
acut
chronic
worsen
asthma
base
aberr
immun
respons
nonpathogen
stimuli
airway
lead
chronic
inflammatori
respons
relev
pathogenesi
diseas
inflamm
affect
compart
airway
includ
upper
respiratori
tract
nose
major
physiolog
effect
compris
mediums
bronchi
small
airway
although
spectrum
clinic
symptom
vari
wide
typic
occur
episod
underli
chronic
inflamm
alway
present
even
absenc
continu
allergen
exposur
period
rel
minor
symptom
type
cell
cellular
compon
involv
inflammatori
process
appear
compar
regardless
asthma
phenotyp
type
allergi
nonimmunolog
trigger
like
exercis
smoke
age
complex
interact
multicellular
inflammatori
infiltr
parenchym
pulmonari
cell
organis
complex
network
interact
bioactiv
mediat
numer
cytokin
antibodi
growth
factor
stimul
inhibit
immun
respons
increas
evid
deregul
endogen
immun
regul
process
least
part
respons
manifest
aggrav
diseas
mediat
identifi
involv
among
chemokin
recruit
inflammatori
cell
like
eosinophil
cell
blood
vessel
airway
exampl
eotaxin
thymu
activationregul
chemokin
tarc
macrophagederiv
chemokin
mdc
cysteinyl
leukotrien
potent
bronchoconstrictor
proinflammtori
potenc
deriv
mast
cell
eosinophil
cytokin
orchestr
inflammatori
respons
interleukin
il
like
tumour
necrosi
factor
alpha
amplifi
inflamm
wherea
granulocyt
macrophag
coloni
stimul
factor
gmcsf
prolong
eosinophil
surviv
mediat
eosinophil
differenti
surviv
import
cell
differenti
requir
ige
immunoglobulin
e
format
histamin
releas
mast
cell
variou
proinflammatori
function
lead
among
other
vasodilat
bronchoconstrict
nitric
oxid
function
vasodil
allerg
inflamm
airway
activ
induc
synthas
bronchoepitheli
cell
caus
higher
level
eg
asthmat
patient
prostaglandin
potent
bronchoconstrictor
releas
mast
cell
chemotact
properti
cell
chronic
inflamm
often
accompani
remodel
tissu
remodel
seen
adapt
injuri
mechan
demand
chang
geometri
structur
properti
within
airway
wall
patient
poorli
control
asthma
develop
progress
persist
airflow
limit
longer
diseas
durat
insuffici
antiinflammatori
therapi
provid
evid
airway
remodel
play
crucial
role
impair
lung
function
occur
wide
rang
tissu
organ
observ
almost
tissu
suscept
repeat
chronic
injuri
asthmat
inflamm
lead
structur
chang
airway
includ
chang
epithelium
subepitheli
fibrosi
increas
airway
smooth
muscl
mass
hyperplas
hypertroph
composit
decreas
distanc
smooth
muscl
epithelium
thicken
reticular
basement
membran
dysregul
extracellular
matrix
mucou
gland
goblet
cell
hyperplasia
vascular
chang
oedema
chang
relat
sever
diseas
may
result
rel
irrevers
narrow
airway
relat
airway
hyperrespons
thick
reticular
basement
membran
correl
airflow
obstruct
increas
airway
hyperrespons
mani
cell
contribut
tissu
injuri
repair
process
includ
inflammatori
structur
cell
type
cell
domin
type
cell
promot
subepitheli
fibrosi
hyperplasia
airway
smooth
muscl
cell
regulatori
tcell
exhibit
cytokinedepend
suppress
mechan
via
secret
induc
via
among
other
transcript
extracellular
matrix
protein
ecm
lead
subendotheli
fibrosi
collagen
deposit
increas
accumul
actincontain
smooth
muscl
cell
regul
proinflammatori
chemokin
rant
regul
activ
normal
cell
express
secret
eotaxin
eosinophil
accumul
airway
asthmat
produc
mani
proinflammatori
remodel
cytokin
includ
airway
epitheli
cell
mesenchym
cell
form
trophic
unit
epitheli
damag
occur
typic
respons
environment
exposur
result
product
signal
act
underli
mesenchym
propag
amplifi
inflammatori
remodel
respons
submucosa
allergen
sensitis
may
consequ
defect
airway
epithelium
lead
activ
dendrit
cell
toward
promot
respons
activ
epitheli
cell
produc
via
activ
eg
infiltr
lymphocyt
numer
chemokin
includ
rant
eotaxin
releas
growth
factor
epiderm
growth
factor
egf
plateletderiv
growth
factor
pdgf
vascular
endotheli
growth
factor
vegf
advoc
airway
smooth
muscl
prolifer
angiogenesi
ecm
protein
deposit
airway
smooth
muscl
cell
import
effort
cell
whole
inflammatori
process
evid
either
hypertrophi
hyperplasia
report
mild
moder
sever
asthma
correl
sever
diseas
myocyt
prolifer
respons
growth
factor
inflammatori
mediat
also
increas
size
shape
migrat
airway
smooth
muscl
cell
respond
inflammatori
process
particip
remodel
process
releas
cytokin
like
interferongamma
chemokin
like
rant
eotaxin
macrophag
inflammatori
protein
ecm
protein
mani
cytokin
induc
express
tolllik
receptor
tlr
airway
smooth
muscl
cell
gramneg
bacteria
suggest
promot
airway
hyperrespons
tlr
cell
infect
gener
viralbacteri
compon
activ
tlr
thu
contribut
remodel
fibroblast
differenti
respons
variou
stimuli
myofibroblast
secret
among
inflammatori
mediat
ecm
protein
sever
asthma
insuffici
antiinflammatori
drugtreat
asthma
subepitheli
fibrosi
occur
increas
deposit
ecm
protein
includ
collagen
iii
v
proteoglycan
tenascin
fibronectin
deposit
ecm
protein
regul
myofibroblast
imbal
matrix
metalloproteinas
degrad
collagen
tissu
inhibitor
matrix
metalloproteinas
secret
fibroblast
mucu
gland
activ
asthma
increas
mucu
hypersecret
goblet
cell
prolifer
common
featur
poorli
control
asthma
predominantli
associ
intracellular
signal
pathway
shown
involv
upregul
mucin
synthesi
promot
goblet
cell
hyperplasia
howev
goblet
cell
hyperplasia
gener
featur
asthma
found
subgroup
patient
environment
factor
allergen
also
viru
bacteri
infect
lead
destruct
epitheli
barrier
airway
thu
contribut
remodel
vice
versa
inflammatori
damag
airway
allevi
infect
eventu
lead
asthma
exacerb
explain
suscept
asthmat
airway
respiratori
germ
impact
health
poorli
control
asthmat
patient
furthermor
inhal
viru
bacteria
even
ingest
germ
eg
parasit
interact
immun
system
may
enhanc
restrain
immunogen
respons
utilis
inflammatori
pathway
describ
infect
earli
life
link
subsequ
respiratori
morbid
also
protect
toward
eventu
develop
allerg
diseas
possibl
asthma
propos
hygien
hypothesi
wheez
ill
includ
asthma
exacerb
associ
viral
bacteri
respiratori
infect
patient
age
interestingli
viral
infect
induc
wheez
also
protector
develop
allerg
diseas
respiratori
viral
infect
associ
asthma
exacerb
seen
children
well
adult
clear
respiratori
infect
instig
diseas
progress
intensifi
sever
diseas
wheez
episod
due
respiratori
infect
may
diminish
age
individu
start
earli
life
mark
begin
lifelong
asthma
carrier
mani
viru
known
trigger
wheez
event
includ
respiratori
syncyti
viru
rsv
human
rhinoviru
hrv
metapneumoviru
parainfluenza
coronaviru
relat
viral
infect
preval
asthma
best
studi
rsv
hrv
natur
experiment
viral
infect
induc
activ
transcript
factor
like
initi
gene
transcript
cytokin
chemokin
product
membran
cofactor
protein
rant
mediat
promot
tissu
infiltr
cell
eosinophil
basophil
activ
releas
mediat
eosinophil
cation
protein
histamin
immunolog
reaction
also
virusspecif
ige
persist
sever
inflamm
seem
pronounc
atop
asthma
compar
healthi
individu
immunolog
imbal
cytokin
releas
inflamm
cascad
airway
inflamm
initi
upper
respiratori
infect
may
result
bronchial
hyperrespons
rsv
bronchiol
persist
asthma
symptom
even
rel
mild
viral
infect
might
induc
less
sever
inflamm
airway
possibl
accompani
prolong
period
bronchial
hyperreact
one
reason
phenomenon
absenc
protect
immunolog
memori
anoth
might
genet
determin
premorbid
abnorm
simpli
matern
smoke
pregnanc
involuntari
second
hand
smoke
exposur
sinc
earli
year
also
known
promot
half
patient
develop
rsv
bronchiol
suffer
persist
episod
wheez
earli
childhood
child
born
peak
winter
bronchiol
season
appar
high
risk
develop
asthma
anoth
risk
factor
seem
rsvmediat
wheez
ill
earli
life
eventu
lead
subsequ
persist
wheez
asthma
child
begin
go
school
variou
reason
discuss
phenomenon
immatur
immun
system
time
initi
infect
result
slower
recoveri
might
even
caus
sever
symptom
later
year
although
start
infect
rel
mild
differ
genet
background
genet
suscept
viru
strain
variabl
howev
investig
demonstr
associ
may
addit
genet
predisposit
develop
asthma
later
year
exist
discuss
twin
registri
studi
denmark
also
hrv
trigger
common
cold
respiratori
tract
infect
caus
bronchiol
promot
later
asthma
jackson
et
al
calcul
risk
factor
hrv
rsvinduc
wheez
ill
first
year
life
probabl
asthma
develop
age
odd
ratio
ci
rsvrelat
wheez
ci
hsv
hrvrelat
wheez
first
year
highest
children
acquir
addit
aeroallergen
sensitis
contrast
sensitis
first
year
life
promot
effect
asthma
develop
knowledg
host
viru
interact
viral
infect
earli
phase
life
essenti
understand
children
develop
asthma
other
protect
allerg
sensitis
sensit
diagnost
test
base
polymeras
chain
reaction
pcr
microarray
technolog
reveal
respiratori
viral
infect
associ
exacerb
wheez
acut
worsen
asthma
rhinoviru
probabl
import
pathogen
trigger
asthma
attack
rsv
hrv
turn
epidemiolog
studi
often
detect
virus
depend
season
geograph
area
hrv
infect
peak
asthma
hospitalis
spring
autumn
rsv
like
trigger
acut
asthma
symptom
winter
time
although
clear
evid
viru
infect
trigger
asthma
exacerb
clear
evid
asthma
patient
cold
healthi
individu
asthmat
may
suffer
extend
durat
ill
increas
sever
lower
respiratori
tract
symptom
find
suggest
respons
viral
infect
frequenc
differ
suscept
healthi
patient
atopi
promot
sever
ill
nonallerg
asthma
infect
respiratori
virus
delay
viral
clearanc
increas
viral
load
upper
respiratori
tract
obvious
reason
phenomenon
author
suggest
abnorm
antivir
activ
eg
reduc
gener
interferon
viru
infect
possibl
reason
increas
suscept
disrupt
innat
immun
host
defenc
pathway
antagonist
interact
allerg
inflamm
antivir
immun
epidemiolog
studi
demonstr
infect
within
first
year
life
protect
develop
atopi
allergi
hygien
hypothesi
drawn
observ
individu
suscept
allerg
diseas
promot
chang
interact
immun
system
microb
follow
find
hint
infect
earli
life
may
protect
atopi
children
sibl
less
skinprick
test
reactiv
lack
wheez
lower
respiratori
tract
infect
earli
life
coincid
low
ige
level
serum
use
daycar
centr
correl
invers
preval
typic
allerg
symptom
children
grew
close
proxim
farm
close
livestock
within
first
year
life
whose
parent
farmer
also
fewer
allergi
grew
cleaner
hygien
condit
huge
list
put
protect
factor
discuss
high
exposur
endotoxin
exposur
livestock
especi
cattl
tradit
diet
ingest
unpasteuris
milk
mani
strong
respons
delayedtyp
hypersensit
mycobacterium
tuberculosi
also
reduc
atopi
incid
hygien
hypothesi
unanim
accept
epidemiolog
inconsist
exist
regard
benefici
also
diseas
promot
function
microb
mani
observ
seem
contradict
hygien
hypothesi
exampl
regardless
lack
cleanli
inner
citi
allerg
sensitis
exampl
cockroach
allergen
increas
prevail
version
hypothesi
focus
protect
role
intracellular
mild
pathogen
ingest
faecal
contamin
environ
water
food
also
includ
microb
exposur
vanguard
longlast
immun
respons
thu
protect
allergi
import
viral
infect
sourc
asthma
exacerb
chronic
inflamm
airway
children
adult
well
demonstr
role
bacteri
infect
develop
stabl
asthma
acut
asthma
exacerb
remain
controversi
bacteri
respiratori
pathogen
assum
potenti
role
pathogenesi
asthma
chlamydophila
pneumonia
previous
chlamydia
pneumonia
mycoplasma
pneumonia
commonli
discuss
context
although
cascad
pathogenet
mechan
atyp
bacteri
infect
airway
inflamm
asthma
yet
complet
understood
still
enough
data
accumul
support
hypothesi
greater
limit
confirm
associ
atyp
respiratori
infect
asthma
lack
standardis
laboratori
method
detect
pathogen
practic
even
ethic
difficulti
obtain
clinic
sampl
lower
respiratori
tract
asymptomat
popul
geograph
tempor
variat
natur
histori
infect
seem
also
play
role
commonli
use
method
like
serolog
detect
igg
antibodi
distinguish
previou
infect
chronic
colonis
reactiv
chronic
infect
preval
igg
antibodi
atyp
bacteria
high
among
gener
popul
allow
comparison
asthmat
patient
control
group
hand
acut
infect
reinfect
alway
accompani
igm
antibodi
product
caus
even
greater
uncertainti
howev
molecular
method
like
pcr
enabl
recent
year
detect
pathogen
higher
sensit
import
case
chronic
colonis
bacteri
load
low
higher
specif
also
import
order
avoid
usual
observ
crossreact
recent
emerg
reversetranscriptas
pcr
base
detect
messeng
rna
allow
discrimin
viabl
nonviabl
organ
result
better
differenti
chronic
colonis
viabl
bacteria
preced
infect
nonviabl
bacteria
addit
refin
laboratori
method
numer
human
studi
outlin
clinic
relev
atyp
infect
asthma
anim
model
highlight
pathophysiolog
pathway
infect
promot
lung
inflamm
airway
remodel
c
pneumonia
predomin
implic
pathogen
communityacquir
pneumonia
obligatori
intracellular
bacterium
also
potenc
caus
chronic
infect
affect
cell
c
pneumonia
infect
associ
product
releas
sever
cytokin
major
role
molecul
attract
immun
cell
like
macrophag
respons
bacteri
presenc
howev
recruit
immun
cell
within
airway
wall
may
subsequ
trigger
inflammatori
respons
tissu
damag
predomin
correl
immun
system
activ
structur
chang
airway
mediat
mmp
mmp
physiolog
inhibitor
tissu
inhibitor
timp
produc
differ
structur
inflammatori
cell
mainli
smooth
muscl
cell
submucosa
stimul
macrophag
recruit
lung
proteolyticantiproteolyt
activ
protein
regul
sever
cytokin
thought
signific
variou
physiolog
process
like
heal
develop
contrari
dysfunct
proteolyt
system
provok
deregul
express
chang
biolog
activ
involv
wide
rang
lung
diseas
includ
chronic
obstruct
pulmonari
diseas
lung
fibrosi
lung
cancer
asthma
addit
mmp
caus
airway
wall
remodel
see
sever
sophist
pathophysiolog
mechan
also
propos
linkag
atyp
infect
asthma
emerg
bodi
molecular
studi
shown
c
pneumonia
abil
inhibit
affect
cell
apoptosi
order
assur
longev
host
precondit
viabil
oblig
intracellular
pathogen
impair
apoptot
mechan
enhanc
chronic
inflamm
favour
persist
c
pneumonia
infect
creat
link
chronic
asthma
inflammatori
manifest
hand
chronic
affect
cell
appear
increas
suscept
respiratori
virus
due
impair
apoptosi
may
provid
evid
atyp
infect
also
indirectli
contribut
acut
exacerb
asthma
viralbacteri
coinfect
consist
repres
exampl
coexist
caus
factor
interact
parallel
discuss
even
infecti
noninfecti
agent
like
pollut
allergen
nutrit
element
stress
condit
discuss
theori
context
induct
airway
sensitis
allergen
ground
chronic
c
pneumonia
infect
cellular
molecular
studi
partli
elucid
potenti
role
immun
system
bacterialallergen
interact
comprehens
analysi
remain
done
order
evalu
involv
mechan
contrari
pneumonia
extracellular
microorgan
destroy
ciliat
epithelium
attach
bronchial
mucosa
far
associ
wide
spectrum
acut
respiratori
infect
pneumonia
exacerb
bronchiti
bronchiol
sinus
median
otiti
pneumonia
infect
also
accompani
similarli
observ
c
pneumonia
increas
product
iga
antibodi
greater
mast
cell
tissu
infiltr
airway
may
subsequ
play
role
chronic
cours
asthma
previou
describ
biolog
mechan
although
mani
still
discuss
indic
atyp
respiratori
infect
may
contribut
inflamm
remodel
airway
asthmat
patient
regardless
caus
relationship
atyp
bacteria
asthma
remain
unclear
infect
patient
develop
asthma
peopl
asthma
found
becom
infect
main
question
answer
whether
atyp
infect
make
develop
asthma
like
preexist
alter
airway
favour
colonis
persist
pathogen
lead
increas
detect
asthma
epiphenomenon
etiolog
correl
howev
despit
absenc
definit
caus
direct
mani
control
observ
clinic
studi
demonstr
associ
chronic
stabl
asthma
atyp
bacteria
infect
subject
found
elev
marker
inflamm
increas
sever
obstruct
identifi
higher
daytim
symptom
score
requir
high
dose
inhal
corticosteroid
comparison
noninfect
control
strong
connect
acut
exacerb
asthma
infect
c
pneumonia
andor
pneumonia
also
identifi
major
research
protocol
conduct
purpos
insuffici
data
allow
reliabl
conclus
role
atyp
bacteria
lateonset
asthma
import
note
inadequ
laboratori
method
use
detect
pathogen
may
influenc
result
clinic
studi
correl
confirm
underl
need
standardis
diagnost
techniqu
set
addit
atyp
bacteria
respiratori
recent
nonrespiratori
bacteri
speci
drawn
attent
concern
role
asthma
helicobact
pylori
exampl
one
nonrespiratori
pathogen
assum
except
local
complic
system
immunomodulatori
effect
may
prevent
develop
asthma
invers
preval
h
pylori
infect
asthma
consist
confirm
mani
differ
popul
geograph
area
still
remain
unclear
etiolog
associ
observ
trigger
lifestyl
trend
even
incident
occur
phenomenon
erad
therapi
recommend
treatment
strategi
asthma
prospect
studi
lack
field
much
research
requir
commun
bacteria
human
gut
also
thought
immunomodulatori
effect
innat
adapt
immun
host
interact
immun
cell
intestin
mucosa
interact
lead
activ
tolerogen
dendrit
cell
ii
balanc
differenti
import
lifetim
mainten
immun
toler
host
establish
intestin
microbiota
disrupt
earlylif
event
like
antibiot
use
tolerogen
immunomodulatori
effect
minimis
result
overproduct
cytokin
risk
factor
autoimmun
allerg
diseas
intervent
method
potenti
probiot
bifidobacterium
lactobacillu
strain
aim
creat
healthi
microflora
intens
test
treatment
prevent
mani
allerg
diseas
like
atop
dermat
allerg
rhiniti
asthma
far
avail
studi
provid
contradictori
result
generalis
posit
effect
allerg
condit
care
consid
suffici
evid
avail
suggest
exposur
staphylococcu
aureu
andor
enterotoxin
function
environment
risk
factor
develop
sever
asthma
local
system
releas
enterotoxin
show
superantigen
activ
may
provok
eosinophil
stimul
multiclon
ige
product
lead
deterior
upper
lower
respiratori
tract
atop
diseas
specif
ige
antibodi
aureu
enterotoxin
like
found
patient
nasal
polyp
allerg
rhiniti
chronic
rhinosinus
asthma
may
indic
futur
therapeut
target
role
respiratori
bacteria
like
haemophilu
influenza
moraxella
catarrhali
streptococcu
pneumonia
mainli
discuss
framework
hygien
hypothesi
see
infect
earli
year
claim
protect
effect
asthma
atopi
develop
contrast
protect
pathogen
often
caus
sever
persist
wheez
preschool
children
group
may
significantli
benefit
longterm
antibiot
treatment
also
found
neonat
colonis
hypopharyng
region
increas
risk
recurr
wheez
asthma
within
first
year
life
particularli
evid
associ
pathogen
subset
stabl
asthma
known
neutrophil
asthma
inflamm
primarili
mediat
neutrophil
less
eosinophil
h
influenza
isol
airway
neutrophil
peopl
asthma
infectioninduc
inflamm
mediat
express
asthma
complex
diseas
great
heterogen
clinic
featur
even
greater
heterogen
treatment
respons
result
individu
environment
genet
pressur
therapeut
measur
alway
adequ
cover
differ
subtyp
diseas
even
patient
clinic
phenotyp
may
benefit
equal
complex
increas
one
pathogen
involv
pathogenesi
accumul
number
new
therapi
emerg
highli
effici
especi
patient
persist
asthma
benefit
optimis
health
care
also
challeng
select
right
target
group
compound
opportun
phenotypedriven
treatment
option
may
open
way
personalis
health
care
asthma
antibiot
especi
macrolid
erythromycin
clarithromycin
roxithromycin
azithromycin
test
context
aim
persist
atyp
infect
chronic
asthma
acut
exacerb
caus
atyp
bacteria
effect
recognis
time
well
dose
depend
underli
mechan
action
complet
clarifi
macrolid
except
obviou
antimicrobi
properti
shown
exert
antiinflammatori
immunomodulatori
activ
suppress
product
cytokin
inflam
tissu
report
reduc
airway
hyperrespons
improv
pulmonari
function
sometim
soften
symptom
still
remain
matter
debat
antimicrobi
effect
result
limit
bacteri
load
antiinflammatori
action
macrolid
reduct
bacteria
subsequ
follow
decreas
cytokin
express
much
addit
research
requir
defin
right
agent
right
patient
optimum
dosag
durat
therapi
adequ
treatment
macrolid
treatment
recommend
longterm
treatment
option
asthma
patient
contrari
antibiot
exposur
pregnanc
within
first
year
life
thought
associ
increas
risk
childhood
asthma
incomplet
establish
microflora
modifi
natur
exposur
pathogen
describ
hygien
hypothesi
studi
conduct
clarifi
matter
confirm
increas
risk
develop
asthma
later
year
mani
factor
confound
relationship
epidemiolog
data
suggest
helminth
infect
may
protect
asthma
allerg
diseas
rare
observ
popul
preval
intestin
parasit
high
thought
immunomodulatori
effect
parasit
suppos
influenc
atop
respons
mediat
regul
differenti
ige
product
howev
metaanalysi
epidemiolog
studi
confirm
gener
conclus
infect
hookworm
found
protect
ascari
lumbricoid
associ
increas
risk
asthma
signific
effect
found
speci
trichuri
trichiura
earli
life
associ
less
posit
prick
test
childhood
toxocara
infect
increas
risk
wheez
popul
appar
posit
neg
effect
helminth
allergi
asthma
differ
differ
speci
suggest
mani
factor
also
caus
interact
chronic
time
parasit
burden
diseas
relationship
inflamm
remodel
pathogen
role
viral
bacteri
infect
airway
asthmat
patient
still
highli
debat
incomplet
understood
presenc
airway
inflamm
alway
translat
irrevers
chang
mani
case
alway
clearcut
relationship
degre
inflamm
level
remodel
fig
remodel
process
paediatr
popul
rais
question
mean
chronic
inflamm
genet
suscept
need
explor
area
certainli
challeng
regard
develop
new
therapeut
compound
aim
inhibit
specif
inflammatori
pathway
includ
trigger
virus
bacteria
final
identif
biomark
identifi
remodel
essenti
studi
process
detail
identifi
patient
particularli
risk
develop
irrevers
chang
ii
clarifi
effect
antiinflammatori
treatment
regim
